Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1991 Apr;87(4):1402–1412. doi: 10.1172/JCI115146

Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.

M Mukoyama 1, K Nakao 1, K Hosoda 1, S Suga 1, Y Saito 1, Y Ogawa 1, G Shirakami 1, M Jougasaki 1, K Obata 1, H Yasue 1, et al.
PMCID: PMC295184  PMID: 1849149

Abstract

Using a specific radioimmunoassay for human brain natriuretic peptide (hBNP) with a monoclonal antibody, we have investigated its synthesis, secretion, and clearance in comparison with those of atrial natriuretic peptide (ANP) in normal subjects and patients with congestive heart failure (CHF). Mean BNP-like immunoreactivity (-LI) levels in normal atrium and ventricle were 250 and 18 pmol/g, respectively. The plasma BNP-LI level in normal subjects was 0.90 +/- 0.07 fmol/ml, which was 16% of the ANP-LI level. In contrast, the plasma BNP-LI level markedly increased in patients with CHF in proportion to its severity, and surpassed the ANP-LI level in severe cases. There was a significant step-up of the plasma BNP-LI level in the coronary sinus (CS) compared with that in the aortic root (Ao) and the difference between these BNP-LI levels, delta(CS-Ao)BNP, also increased with the severity of CHF. In addition, the step-up of the BNP-LI level in the anterior interventricular vein [delta(AIV-Ao)BNP] was comparable to delta(CS-Ao)BNP, indicating that BNP is secreted mainly from the ventricle. Predominant BNP synthesis in the ventricle was also confirmed by Northern blot analysis. Catheterization and pharmacokinetic studies revealed that hBNP is cleared from the circulation more slowly than alpha-hANP; this was in part attributed to lower (about 7%) binding affinity of hBNP to clearance receptors than that of alpha-hANP. A predominant molecular form of BNP-LI in the heart and plasma was a 3-kD form corresponding to hBNP. These results indicate that BNP is a novel cardiac hormone secreted predominantly from the ventricle, and that the synthesis, secretion and clearance of BNP differ from those of ANP, suggesting discrete physiological and pathophysiological roles of BNP in a dual natriuretic peptide system.

Full text

PDF
1402

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aburaya M., Hino J., Minamino N., Kangawa K., Matsuo H. Isolation and identification of rat brain natriuretic peptides in cardiac atrium. Biochem Biophys Res Commun. 1989 Aug 30;163(1):226–232. doi: 10.1016/0006-291x(89)92125-6. [DOI] [PubMed] [Google Scholar]
  2. Aburaya M., Minamino N., Kangawa K., Tanaka K., Matsuo H. Distribution and molecular forms of brain natriuretic peptide in porcine heart and blood. Biochem Biophys Res Commun. 1989 Dec 15;165(2):872–879. doi: 10.1016/s0006-291x(89)80047-6. [DOI] [PubMed] [Google Scholar]
  3. Arai H., Nakao K., Saito Y., Morii N., Sugawara A., Yamada T., Itoh H., Shiono S., Mukoyama M., Ohkubo H. Augmented expression of atrial natriuretic polypeptide gene in ventricles of spontaneously hypertensive rats (SHR) and SHR-stroke prone. Circ Res. 1988 May;62(5):926–930. doi: 10.1161/01.res.62.5.926. [DOI] [PubMed] [Google Scholar]
  4. Bloch K. D., Seidman J. G., Naftilan J. D., Fallon J. T., Seidman C. E. Neonatal atria and ventricles secrete atrial natriuretic factor via tissue-specific secretory pathways. Cell. 1986 Dec 5;47(5):695–702. doi: 10.1016/0092-8674(86)90512-x. [DOI] [PubMed] [Google Scholar]
  5. Burnett J. C., Jr, Kao P. C., Hu D. C., Heser D. W., Heublein D., Granger J. P., Opgenorth T. J., Reeder G. S. Atrial natriuretic peptide elevation in congestive heart failure in the human. Science. 1986 Mar 7;231(4742):1145–1147. doi: 10.1126/science.2935937. [DOI] [PubMed] [Google Scholar]
  6. Cantin M., Genest J. The heart and the atrial natriuretic factor. Endocr Rev. 1985 Spring;6(2):107–127. doi: 10.1210/edrv-6-2-107. [DOI] [PubMed] [Google Scholar]
  7. Chang M. S., Lowe D. G., Lewis M., Hellmiss R., Chen E., Goeddel D. V. Differential activation by atrial and brain natriuretic peptides of two different receptor guanylate cyclases. Nature. 1989 Sep 7;341(6237):68–72. doi: 10.1038/341068a0. [DOI] [PubMed] [Google Scholar]
  8. Chinkers M., Garbers D. L., Chang M. S., Lowe D. G., Chin H. M., Goeddel D. V., Schulz S. A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor. Nature. 1989 Mar 2;338(6210):78–83. doi: 10.1038/338078a0. [DOI] [PubMed] [Google Scholar]
  9. Cody R. J., Atlas S. A., Laragh J. H., Kubo S. H., Covit A. B., Ryman K. S., Shaknovich A., Pondolfino K., Clark M., Camargo M. J. Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion. J Clin Invest. 1986 Nov;78(5):1362–1374. doi: 10.1172/JCI112723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Edwards B. S., Ackermann D. M., Lee M. E., Reeder G. S., Wold L. E., Burnett J. C., Jr Identification of atrial natriuretic factor within ventricular tissue in hamsters and humans with congestive heart failure. J Clin Invest. 1988 Jan;81(1):82–86. doi: 10.1172/JCI113314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fuller F., Porter J. G., Arfsten A. E., Miller J., Schilling J. W., Scarborough R. M., Lewicki J. A., Schenk D. B. Atrial natriuretic peptide clearance receptor. Complete sequence and functional expression of cDNA clones. J Biol Chem. 1988 Jul 5;263(19):9395–9401. [PubMed] [Google Scholar]
  12. GENSINI G. G., DIGIORGI S., COSKUN O., PALACIO A., KELLY A. E. ANATOMY OF THE CORONARY CIRCULATION IN LIVING MAN; CORONARY VENOGRAPHY. Circulation. 1965 May;31:778–784. doi: 10.1161/01.cir.31.5.778. [DOI] [PubMed] [Google Scholar]
  13. Gardner D. G., Deschepper C. F., Ganong W. F., Hane S., Fiddes J., Baxter J. D., Lewicki J. Extra-atrial expression of the gene for atrial natriuretic factor. Proc Natl Acad Sci U S A. 1986 Sep;83(18):6697–6701. doi: 10.1073/pnas.83.18.6697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hashida S., Ishikawa E., Nakao K., Mukoyama M., Imura H. Enzyme immunoassay for alpha-human atrial natriuretic polypeptide--direct measurement of plasma level. Clin Chim Acta. 1988 Jun 30;175(1):11–17. doi: 10.1016/0009-8981(88)90030-7. [DOI] [PubMed] [Google Scholar]
  15. Itoh H., Nakao K., Kambayashi Y., Hosoda K., Saito Y., Yamada T., Mukoyama M., Arai H., Shirakami G., Suga S. Occurrence of a novel cardiac natriuretic peptide in rats. Biochem Biophys Res Commun. 1989 Jun 15;161(2):732–739. doi: 10.1016/0006-291x(89)92661-2. [DOI] [PubMed] [Google Scholar]
  16. Itoh H., Nakao K., Mukoyama M., Yamada T., Hosoda K., Shirakami G., Morii N., Sugawara A., Saito Y., Shiono S. Chronic blockade of endogenous atrial natriuretic polypeptide (ANP) by monoclonal antibody against ANP accelerates the development of hypertension in spontaneously hypertensive and deoxycorticosterone acetate-salt-hypertensive rats. J Clin Invest. 1989 Jul;84(1):145–154. doi: 10.1172/JCI114134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Itoh H., Nakao K., Yamada T., Shirakami G., Kangawa K., Minamino N., Matsuo H., Imura H. Antidipsogenic action of a novel peptide, 'brain natriuretic peptide', in rats. Eur J Pharmacol. 1988 May 20;150(1-2):193–196. doi: 10.1016/0014-2999(88)90769-8. [DOI] [PubMed] [Google Scholar]
  18. Jougasaki M., Yasue H., Okumura K., Mukoyama M., Saito Y., Nakao K., Takahashi K. Atrial natriuretic peptide in the ventricles of patients with dilated cardiomyopathy and human foetuses. Histochem J. 1989 Dec;21(12):715–720. doi: 10.1007/BF01002837. [DOI] [PubMed] [Google Scholar]
  19. Kambayashi Y., Nakao K., Itoh H., Hosoda K., Saito Y., Yamada T., Mukoyama M., Arai H., Shirakami G., Suga S. Isolation and sequence determination of rat cardiac natriuretic peptide. Biochem Biophys Res Commun. 1989 Aug 30;163(1):233–240. doi: 10.1016/0006-291x(89)92126-8. [DOI] [PubMed] [Google Scholar]
  20. Kambayashi Y., Nakao K., Mukoyama M., Saito Y., Ogawa Y., Shiono S., Inouye K., Yoshida N., Imura H. Isolation and sequence determination of human brain natriuretic peptide in human atrium. FEBS Lett. 1990 Jan 1;259(2):341–345. doi: 10.1016/0014-5793(90)80043-i. [DOI] [PubMed] [Google Scholar]
  21. Kangawa K., Matsuo H. Purification and complete amino acid sequence of alpha-human atrial natriuretic polypeptide (alpha-hANP). Biochem Biophys Res Commun. 1984 Jan 13;118(1):131–139. doi: 10.1016/0006-291x(84)91077-5. [DOI] [PubMed] [Google Scholar]
  22. Kawata M., Nakao K., Morii N., Kiso Y., Yamashita H., Imura H., Sano Y. Atrial natriuretic polypeptide: topographical distribution in the rat brain by radioimmunoassay and immunohistochemistry. Neuroscience. 1985 Nov;16(3):521–546. doi: 10.1016/0306-4522(85)90190-3. [DOI] [PubMed] [Google Scholar]
  23. Maack T., Suzuki M., Almeida F. A., Nussenzveig D., Scarborough R. M., McEnroe G. A., Lewicki J. A. Physiological role of silent receptors of atrial natriuretic factor. Science. 1987 Oct 30;238(4827):675–678. doi: 10.1126/science.2823385. [DOI] [PubMed] [Google Scholar]
  24. Morii N., Nakao K., Sugawara A., Sakamoto M., Suda M., Shimokura M., Kiso Y., Kihara M., Yamori Y., Imura H. Occurrence of atrial natriuretic polypeptide in brain. Biochem Biophys Res Commun. 1985 Mar 15;127(2):413–419. doi: 10.1016/s0006-291x(85)80176-5. [DOI] [PubMed] [Google Scholar]
  25. Mukoyama M., Nakao K., Yamada T., Itoh H., Hosoda K., Saito Y., Sugawara A., Arai H., Shirakami G., Morii N. Preparation of monoclonal antibodies against atrial natriuretic polypeptide precursor and application to highly sensitive sandwich enzyme immunoassay. J Hypertens Suppl. 1988 Dec;6(4):S320–S322. doi: 10.1097/00004872-198812040-00099. [DOI] [PubMed] [Google Scholar]
  26. Mukoyama M., Nakao K., Yamada T., Itoh H., Sugawara A., Saito Y., Arai H., Hosoda K., Shirakami G., Morii N. A monoclonal antibody against N-terminus of alpha-atrial natriuretic polypeptide (alpha-ANP): a useful tool for preferential detection of naturally circulating ANP. Biochem Biophys Res Commun. 1988 Mar 30;151(3):1277–1284. [PubMed] [Google Scholar]
  27. Nakao K., Morii N., Itoh H., Yamada T., Shiono S., Sugawara A., Saito Y., Mukoyama M., Arai H., Sakamoto M. Atrial natriuretic polypeptide in the brain: implication of central cardiovascular control. J Hypertens Suppl. 1986 Dec;4(6):S492–S496. [PubMed] [Google Scholar]
  28. Nakao K., Sugawara A., Morii N., Sakamoto M., Suda M., Soneda J., Ban T., Kihara M., Yamori Y., Shimokura M. Radioimmunoassay for alpha-human and rat atrial natriuretic polypeptide. Biochem Biophys Res Commun. 1984 Nov 14;124(3):815–821. doi: 10.1016/0006-291x(84)91030-1. [DOI] [PubMed] [Google Scholar]
  29. Nakao K., Sugawara A., Morii N., Sakamoto M., Yamada T., Itoh H., Shiono S., Saito Y., Nishimura K., Ban T. The pharmacokinetics of alpha-human atrial natriuretic polypeptide in healthy subjects. Eur J Clin Pharmacol. 1986;31(1):101–103. doi: 10.1007/BF00870995. [DOI] [PubMed] [Google Scholar]
  30. Nakao K., Sugawara A., Shiono S., Saito Y., Morii N., Yamada T., Itoh H., Mukoyama M., Arai H., Sakamoto M. Secretory form of atrial natriuretic polypeptide as cardiac hormone in humans and rats. Can J Physiol Pharmacol. 1987 Aug;65(8):1756–1761. doi: 10.1139/y87-275. [DOI] [PubMed] [Google Scholar]
  31. Needleman P., Adams S. P., Cole B. R., Currie M. G., Geller D. M., Michener M. L., Saper C. B., Schwartz D., Standaert D. G. Atriopeptins as cardiac hormones. Hypertension. 1985 Jul-Aug;7(4):469–482. doi: 10.1161/01.hyp.7.4.469. [DOI] [PubMed] [Google Scholar]
  32. Ogawa Y., Nakao K., Mukoyama M., Shirakami G., Itoh H., Hosoda K., Saito Y., Arai H., Suga S., Jougasaki M. Rat brain natriuretic peptide--tissue distribution and molecular form. Endocrinology. 1990 Apr;126(4):2225–2227. doi: 10.1210/endo-126-4-2225. [DOI] [PubMed] [Google Scholar]
  33. Saito Y., Nakao K., Arai H., Nishimura K., Okumura K., Obata K., Takemura G., Fujiwara H., Sugawara A., Yamada T. Augmented expression of atrial natriuretic polypeptide gene in ventricle of human failing heart. J Clin Invest. 1989 Jan;83(1):298–305. doi: 10.1172/JCI113872. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Saito Y., Nakao K., Itoh H., Yamada T., Mukoyama M., Arai H., Hosoda K., Shirakami G., Suga S., Minamino N. Brain natriuretic peptide is a novel cardiac hormone. Biochem Biophys Res Commun. 1989 Jan 31;158(2):360–368. doi: 10.1016/s0006-291x(89)80056-7. [DOI] [PubMed] [Google Scholar]
  35. Saito Y., Nakao K., Nishimura K., Sugawara A., Okumura K., Obata K., Sonoda R., Ban T., Yasue H., Imura H. Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: beneficial effects on left ventricular function. Circulation. 1987 Jul;76(1):115–124. doi: 10.1161/01.cir.76.1.115. [DOI] [PubMed] [Google Scholar]
  36. Saper C. B., Standaert D. G., Currie M. G., Schwartz D., Geller D. M., Needleman P. Atriopeptin-immunoreactive neurons in the brain: presence in cardiovascular regulatory areas. Science. 1985 Mar 1;227(4690):1047–1049. doi: 10.1126/science.2858127. [DOI] [PubMed] [Google Scholar]
  37. Schulz S., Singh S., Bellet R. A., Singh G., Tubb D. J., Chin H., Garbers D. L. The primary structure of a plasma membrane guanylate cyclase demonstrates diversity within this new receptor family. Cell. 1989 Sep 22;58(6):1155–1162. doi: 10.1016/0092-8674(89)90513-8. [DOI] [PubMed] [Google Scholar]
  38. Shimonaka M., Saheki T., Hagiwara H., Ishido M., Nogi A., Fujita T., Wakita K., Inada Y., Kondo J., Hirose S. Purification of atrial natriuretic peptide receptor from bovine lung. Evidence for a disulfide-linked subunit structure. J Biol Chem. 1987 Apr 25;262(12):5510–5514. [PubMed] [Google Scholar]
  39. Shiono S., Nakao K., Morii N., Yamada T., Itoh H., Sakamoto M., Sugawara A., Saito Y., Katsuura G., Imura H. Nature of atrial natriuretic polypeptide in rat brain. Biochem Biophys Res Commun. 1986 Mar 28;135(3):728–734. doi: 10.1016/0006-291x(86)90989-7. [DOI] [PubMed] [Google Scholar]
  40. Shirakami G., Nakao K., Yamada T., Itoh H., Mori K., Kangawa K., Minamino N., Matsuo H., Imura H. Inhibitory effect of brain natriuretic peptide on central angiotensin II-stimulated pressor response in conscious rats. Neurosci Lett. 1988 Aug 15;91(1):77–83. doi: 10.1016/0304-3940(88)90252-2. [DOI] [PubMed] [Google Scholar]
  41. Sudoh T., Kangawa K., Minamino N., Matsuo H. A new natriuretic peptide in porcine brain. Nature. 1988 Mar 3;332(6159):78–81. doi: 10.1038/332078a0. [DOI] [PubMed] [Google Scholar]
  42. Sudoh T., Maekawa K., Kojima M., Minamino N., Kangawa K., Matsuo H. Cloning and sequence analysis of cDNA encoding a precursor for human brain natriuretic peptide. Biochem Biophys Res Commun. 1989 Mar 31;159(3):1427–1434. doi: 10.1016/0006-291x(89)92269-9. [DOI] [PubMed] [Google Scholar]
  43. Sudoh T., Minamino N., Kangawa K., Matsuo H. Brain natriuretic peptide-32: N-terminal six amino acid extended form of brain natriuretic peptide identified in porcine brain. Biochem Biophys Res Commun. 1988 Sep 15;155(2):726–732. doi: 10.1016/s0006-291x(88)80555-2. [DOI] [PubMed] [Google Scholar]
  44. Sugawara A., Nakao K., Morii N., Sakamoto M., Suda M., Shimokura M., Kiso Y., Kihara M., Yamori Y., Nishimura K. Alpha-human atrial natriuretic polypeptide is released from the heart and circulates in the body. Biochem Biophys Res Commun. 1985 Jun 14;129(2):439–446. doi: 10.1016/0006-291x(85)90170-6. [DOI] [PubMed] [Google Scholar]
  45. Sugawara A., Nakao K., Morii N., Yamada T., Itoh H., Shiono S., Saito Y., Mukoyama M., Arai H., Nishimura K. Synthesis of atrial natriuretic polypeptide in human failing hearts. Evidence for altered processing of atrial natriuretic polypeptide precursor and augmented synthesis of beta-human ANP. J Clin Invest. 1988 Jun;81(6):1962–1970. doi: 10.1172/JCI113544. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Takemura G., Fujiwara H., Horike K., Mukoyama M., Saito Y., Nakao K., Matsuda M., Kawamura A., Ishida M., Kida M. Ventricular expression of atrial natriuretic polypeptide and its relations with hemodynamics and histology in dilated human hearts. Immunohistochemical study of the endomyocardial biopsy specimens. Circulation. 1989 Nov;80(5):1137–1147. doi: 10.1161/01.cir.80.5.1137. [DOI] [PubMed] [Google Scholar]
  47. Tanaka I., Misono K. S., Inagami T. Atrial natriuretic factor in rat hypothalamus, atria and plasma: determination by specific radioimmunoassay. Biochem Biophys Res Commun. 1984 Oct 30;124(2):663–668. doi: 10.1016/0006-291x(84)91606-1. [DOI] [PubMed] [Google Scholar]
  48. Yamada H., Saito Y., Mukoyama M., Nakao K., Yasue H., Ban T., Imura H., Sano Y. Immunohistochemical localization of atrial natriuretic polypeptide (ANP) in human atrial and ventricular myocardiocytes. Histochemistry. 1988;89(5):411–413. doi: 10.1007/BF00492595. [DOI] [PubMed] [Google Scholar]
  49. Yamada T., Nakao K., Itoh H., Shirakami G., Kangawa K., Minamino N., Matsuo H., Imura H. Intracerebroventricular injection of brain natriuretic peptide inhibits vasopressin secretion in conscious rats. Neurosci Lett. 1988 Dec 19;95(1-3):223–228. doi: 10.1016/0304-3940(88)90661-1. [DOI] [PubMed] [Google Scholar]
  50. Yandle T. G., Richards A. M., Nicholls M. G., Cuneo R., Espiner E. A., Livesey J. H. Metabolic clearance rate and plasma half life of alpha-human atrial natriuretic peptide in man. Life Sci. 1986 May 19;38(20):1827–1833. doi: 10.1016/0024-3205(86)90137-2. [DOI] [PubMed] [Google Scholar]
  51. Yasue H., Obata K., Okumura K., Kurose M., Ogawa H., Matsuyama K., Jougasaki M., Saito Y., Nakao K., Imura H. Increased secretion of atrial natriuretic polypeptide from the left ventricle in patients with dilated cardiomyopathy. J Clin Invest. 1989 Jan;83(1):46–51. doi: 10.1172/JCI113883. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. de Bold A. J. Atrial natriuretic factor: a hormone produced by the heart. Science. 1985 Nov 15;230(4727):767–770. doi: 10.1126/science.2932797. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES